Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Report from the 19th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29-30 September 2017.
Kim CA, Ahmed S, Ahmed S, Brunet B, Chalchal H, Deobald R, Doll C, Dupre MP, Gordon V, Lee-Ying RM, Lim H, Liu D, Loree JM, McGhie JP, Mulder K, Park J, Yip B, Wong RP, Zaidi A; Western Canadian Gastrointestinal Cancer Group. Kim CA, et al. Curr Oncol. 2018 Aug;25(4):275-284. doi: 10.3747/co.25.4109. Epub 2018 Aug 14. Curr Oncol. 2018. PMID: 30111968 Free PMC article.
Report from the 21st Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Calgary, Alberta; 20-21 September 2019.
Lee-Ying R, Ahmed O, Ahmed S, Ahmed S, Bathe OF, Brunet B, Dawson L, Davies J, Gordon V, Hebbard P, Kasnik J, Kim CA, Le D, Lee MKC, Lim H, McGhie JP, Mulder K, Park J, Renouf D, Tam V, Visser R, Wong RPW, Zaidi A, Doll C. Lee-Ying R, et al. Curr Oncol. 2021 Sep 21;28(5):3629-3648. doi: 10.3390/curroncol28050310. Curr Oncol. 2021. PMID: 34590606 Free PMC article.
Second-line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real-world eligibility for cabozantinib, regorafenib, and ramucirumab.
Fung AS, Tam VC, Meyers DE, Sim HW, Knox JJ, Zaborska V, Davies J, Ko YJ, Batuyong E, Samawi H, Cheung WY, Lee-Ying R. Fung AS, et al. Cancer Med. 2020 Jul;9(13):4640-4647. doi: 10.1002/cam4.3116. Epub 2020 May 7. Cancer Med. 2020. PMID: 32378799 Free PMC article.
Report from the Western Canadian Gastrointestinal Cancer Consensus Conference Virtual Education Series-Transition from Local to System Therapy and Optimal Sequencing of Systemic Therapy for HCC.
Zaidi A, Ahmed S, Ahmed S, Brunet B, Davies J, Doll C, Dueck DA, Gordon V, Hebbard P, Kim C, Le D, Lee-Ying R, Lim H, Liu D, McGhie JP, Mulder K, Park J, Renouf D, Schellenberg D, Wong RPW, Moser M. Zaidi A, et al. Curr Oncol. 2021 Oct 29;28(6):4317-4327. doi: 10.3390/curroncol28060367. Curr Oncol. 2021. PMID: 34898545 Free PMC article.
Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database.
Alghamdi MA, Amaro CP, Lee-Ying R, Sim HW, Samwi H, Chan KK, Knox JJ, Ko YJ, Swiha M, Batuyong E, Romagnino A, Cheung WY, Tam VC; Hepatocellular Carcinoma - Cancer Health Outcomes Research Database (HCC - CHORD) Consortium. Alghamdi MA, et al. Cancer Med. 2020 Jul;9(14):4918-4928. doi: 10.1002/cam4.3228. Epub 2020 Jun 11. Cancer Med. 2020. PMID: 32529797 Free PMC article.
Report from the 20th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; 28-29 September 2018.
Le DM, Ahmed S, Ahmed S, Brunet B, Davies J, Doll C, Ferguson M, Ginther N, Gordon V, Hamilton T, Hebbard P, Helewa R, Kim CA, Lee-Ying R, Lim H, Loree JM, McGhie JP, Mulder K, Park J, Renouf D, Wong RPW, Zaidi A, Asif T. Le DM, et al. Curr Oncol. 2019 Dec;26(6):e773-e784. doi: 10.3747/co.26.5517. Epub 2019 Dec 1. Curr Oncol. 2019. PMID: 31896948 Free PMC article.
Report from the Western Canadian Gastrointestinal Consensus Cancer Conference-Management of Total Neoadjuvant Therapy in Rectal Cancer.
Lim H, Abraham AG, Ahmed S, Ahmed S, Brown CJ, Brunet B, Davies J, Doll C, Dueck DA, Gordon V, Hagel K, Hebbard P, Kim CA, Le D, Lee-Ying R, McGhie JP, Mulder K, Park J, Renouf DJ, Schellenberg D, Wong RPW, Zaidi A. Lim H, et al. Among authors: lee ying r. Curr Oncol. 2022 Feb 8;29(2):924-927. doi: 10.3390/curroncol29020078. Curr Oncol. 2022. PMID: 35200577 Free PMC article.
Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Cancers-A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference.
Mulder K, Lim H, Ravi D, Ahmed S, Brunet B, Davies J, Doll C, Dueck DA, Gordon V, Hebbard P, Kim CA, Le D, Lee-Ying R, McGhie JP, Park J, Renouf DJ, Schellenberg D, Wong RPW, Zaidi A, Ahmed S. Mulder K, et al. Among authors: lee ying r. Curr Oncol. 2022 Apr 29;29(5):3160-3170. doi: 10.3390/curroncol29050257. Curr Oncol. 2022. PMID: 35621647 Free PMC article.
32 results